News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CLSA Lifts TPs for HANSOH PHARMA, CMS on Expectations of Continued Growth for Pharmas
Three Chinese pharma companies, SINO BIOPHARM (01177.HK), HANSOH PHARMA (03692.HK), and CMS (00867.HK), recorded solid results for 1H25 and achieved double-digit revenue growth in ...
Reset
Send
The window will close in 5 seconds
<Research>CLSA Lifts TPs for HANSOH PHARMA, CMS on Expectations of Continued Growth for Pharmas
Close
Recommend
24
Positive
40
Negative
13
 
SHORT SELL
 
STOCK INFO

Three Chinese pharma companies, SINO BIOPHARM (01177.HK)  +0.450 (+5.829%)    Short selling $282.21M; Ratio 16.271%   , HANSOH PHARMA (03692.HK)  0.000 (0.000%)    Short selling $192.94M; Ratio 38.028%   , and CMS (00867.HK)  -0.350 (-2.538%)    Short selling $22.50M; Ratio 16.131%   , recorded solid results for 1H25 and achieved double-digit revenue growth in both 2H25 and 1H25, according to a research report by CLSA.

In the broker's estimate, their momentum will persist into 2H25 on tailwinds such as the launch of more innovative drugs, increased sales of new products, a more favorable environment for Chinese healthcare insurance spending, and potential business development (BD) revenue.

Related NewsCiti Adds SINO BIOPHARM's TP to HKD10.5, Rating Buy
CLSA reiterated an Outperform rating for SINO BIOPHARM with a target price kept at HKD9.2. Both HANSOH PHARMA's and CMS' ratings were also reiterated as Outperform, with target prices lifted from HKD27.8 to HKD43.1 for the former and from HKD10 to HKD15.6 for the latter.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-22 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.